Potential molecular targets for narrow-spectrum agents to combat Mycoplasma pneumoniae infection and disease
As Mycoplasma pneumoniae macrolide resistance grows and spreads worldwide, it is becoming more important to develop new drugs to prevent infection or limit disease. Because other mycoplasma species have acquired resistance to other classes of antibiotics, it is reasonable to presume that M. pneumoni...
Main Authors: | Mitchell F. Balish, Steven L. Distelhorst |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00205/full |
Similar Items
-
A compendium for Mycoplasma pneumoniae
by: Gretchen Lynn Parrott, et al.
Published: (2016-04-01) -
Cytotoxic molecules of Mycoplasma Pneumoniae and their relationship with biofilm growth
by: Nzenwata, Davidson Ugochukwu
Published: (2021) -
Understanding virulence factors of Mycoplasma penetrans: attachment organelle organization and gene expression
by: Distelhorst, Steven Lindau
Published: (2017) -
Antibody response to Mycoplasma pneumoniae: protection of host and influence on outbreaks?
by: Roger eDumke, et al.
Published: (2016-01-01) -
No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996–2013
by: Karolina Gullsby, et al.
Published: (2016-06-01)